Eyebiotech Limited: EyeBio Raises $65M in Series A Funding to Develop New Generation of Eye Disease Therapies
Leaders in ophthalmology drug development launch new global company to build and advance diversified portfolio of ocular therapies Eyebiotech Limited (EyeBio), a privately held ophthalmology biotechnology